|
1
|
Tang J, Shen L, Yang Q and Zhang C:
Overexpression of metadherin mediates metastasis of osteosarcoma by
regulating epithelial-mesenchymal transition. Cell Prolif.
47:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Montanaro L, Mazzini G, Barbieri S, Vici
M, Nardi-Pantoli A, Govoni M, Donati G, Treré D and Derenzini M:
Different effects of ribosome biogenesis inhibition on cell
proliferation in retinoblastoma protein- and p53-deficient and
proficient human osteosarcoma cell lines. Cell Prolif. 40:532–549.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li G, Cai M, Fu D, Chen K, Sun M, Cai Z
and Cheng B: Heat shock protein 90B1 plays an oncogenic role and is
a target of microRNA-223 in human osteosarcoma. Cell Physiol
Biochem. 30:1481–1490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi
X and Hoang BH: The Wnt signaling pathway: Implications for therapy
in osteosarcoma. Expert Rev Anticancer Ther. 11:1223–1232. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu CL, Tsai HC, Chen ZW, Wu CM, Li TM,
Fong YC and Tang CH: Ras activation mediates WISP-1-induced
increases in cell motility and matrix metalloproteinase expression
in human osteosarcoma. Cell Signal. 25:2812–2822. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bonazzi VF, Stark MS and Hayward NK:
MicroRNA regulation of melanoma progression. Melanoma Res.
22:101–113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martello G, Rosato A, Ferrari F, Manfrin
A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T,
et al: A MicroRNA targeting dicer for metastasis control. Cell.
141:1195–1207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mo YY: MicroRNA regulatory networks and
human disease. Cell Mol Life Sci. 69:3529–3531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang L, Huang Q, Chang J, Wang E and Qiu
X: MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in
lung cancer cells. Exp Lung Res. 37:387–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leotta M, Biamonte L, Raimondi L,
Ronchetti D, Di Martino MT, Botta C, Leone E, Pitari MR, Neri A,
Giordano A, et al: A p53-dependent tumor suppressor network is
induced by selective miR-125a-5p inhibition in multiple myeloma
cells. J Cell Physiol. 229:2106–2116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gattolliat CH, Uguen A, Pesson M, Trillet
K, Simon B, Doucet L, Robaszkiewicz M and Corcos L: MicroRNA and
targeted mRNA expression profiling analysis in human colorectal
adenomas and adenocarcinomas. Eur J Cancer. 51:409–420. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsieh TH, Hsu CY, Tsai CF, Long CY, Wu CH,
Wu DC, Lee JN, Chang WC and Tsai EM: HDAC inhibitors target HDAC5,
upregulate microRNA-125a-5p, and induce apoptosis in breast cancer
cells. Mol Ther. 23:656–666. 2015. View Article : Google Scholar :
|
|
13
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cortez MA, Nicoloso MS, Shimizu M, Rossi
S, Gopisetty G, Molina JR, Carlotti C Jr, Tirapelli D, Neder L,
Brassesco MS, et al: miR-29b and miR-125a regulate podoplanin and
suppress invasion in glioblastoma. Genes Chromosomes Cancer.
49:981–990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hashiguchi Y, Nishida N, Mimori K, Sudo T,
Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y and Mori
M: Down-regulation of miR-125a-3p in human gastric cancer and its
clinicopathological significance. Int J Oncol. 40:1477–1482.
2012.PubMed/NCBI
|
|
16
|
Jiang L, Huang Q, Zhang S, Zhang Q, Chang
J, Qiu X and Wang E: Hsa-miR-125a-3p and hsa-miR-125a-5p are
downregulated in non-small cell lung cancer and have inverse
effects on invasion and migration of lung cancer cells. BMC Cancer.
10:3182010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tiwari A, Shivananda S, Gopinath KS and
Kumar A: MicroRNA-125a reduces proliferation and invasion of oral
squamous cell carcinoma cells by targeting estrogen-related
receptor α: Implications for cancer therapeutics. J Biol Chem.
289:32276–32290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ,
Kim MG, Chang YG, Shen Q, Park WS, Lee JY, et al: Sirtuin7
oncogenic potential in human hepatocellular carcinoma and its
regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Hepatology. 57:1055–1067. 2013. View Article : Google Scholar
|
|
19
|
Ufkin ML, Peterson S, Yang X, Driscoll H,
Duarte C and Sathyanarayana P: miR-125a regulates cell cycle,
proliferation, and apoptosis by targeting the ErbB pathway in acute
myeloid leukemia. Leuk Res. 38:402–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan J, Xiao G, Peng G, Liu D, Wang Z,
Liao Y, Liu Q, Wu M and Yuan X: MiRNA-125a-5p inhibits glioblastoma
cell proliferation and promotes cell differentiation by targeting
TAZ. Biochem Biophys Res Commun. 457:171–176. 2015. View Article : Google Scholar
|
|
21
|
Hsieh TH, Hsu CY, Tsai CF, Long CY, Chai
CY, Hou MF, Lee JN, Wu DC, Wang SC and Tsai EM: miR-125a-5p is a
prognostic biomarker that targets HDAC4 to suppress breast
tumorigenesis. Oncotarget. 6:494–509. 2015.
|
|
22
|
King SE: Matrix metalloproteinases: New
directions toward inhibition in the fight against cancers. Future
Med Chem. 8:297–309. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan D, Dai H and Liu JW: Serum levels of
MMP-11 correlate with clinical outcome in Chinese patients with
advanced gastric adenocarcinoma. BMC Cancer. 11:1512011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kähäri VM and Saarialho-Kere U: Matrix
metalloproteinases and their inhibitors in tumour growth and
invasion. Ann Med. 31:34–45. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Clark AF: New discoveries on the roles of
matrix metalloproteinases in ocular cell biology and pathology.
Invest Ophthalmol Vis Sci. 39:2514–2516. 1998.PubMed/NCBI
|
|
26
|
Valdivia A, Peralta R, Matute-González M,
García Cebada JM, Casasola I, Jiménez-Medrano C, Aguado-Pérez R,
Villegas V, González-Bonilla C, Manuel-Apolinar L, et al:
Co-expression of metalloproteinases 11 and 12 in cervical scrapes
cells from cervical precursor lesions. Int J Clin Exp Pathol.
4:674–682. 2011.PubMed/NCBI
|
|
27
|
Wu D, Li M, Wang L, Zhou Y, Zhou J, Pan H
and Qu P: microRNA145 inhibits cell proliferation, migration and
invasion by targeting matrix metallopeptidase-11 in renal cell
carcinoma. Mol Med Rep. 10:393–398. 2014.PubMed/NCBI
|
|
28
|
Peruzzi D, Mori F, Conforti A, Lazzaro D,
De Rinaldis E, Ciliberto G, La Monica N and Aurisicchio L: MMP11: A
novel target antigen for cancer immunotherapy. Clin Cancer Res.
15:4104–4113. 2009. View Article : Google Scholar : PubMed/NCBI
|
